In another first edition of CRISPR, Penn researchers administer gene-modified T lymphocyte therapy to US patients with cancer – Endpoints News
[ad_1] CRISPR has been tested in American patients for the first time – but maybe not in the way you imagined. The University of Pennsylvania opened the way by administering to two patients with recurrent cancers – one a multiple myeloma and the other a sarcoma – a T cell therapy in which the T … Read more